Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AACR
AACR
Pfizer donates rights to cancer drug
Beckers Hospital Review
Wed, 12/13/23 - 09:39 am
Pfizer
Bavencio
AACR
cancer
J&J, Legend's Carvykti cut risk of progression or death by whopping 74% in earlier myeloma, leaked abstract shows
Fierce Pharma
Wed, 04/19/23 - 11:24 am
CAR-T
Bristol Myers Squibb
JNJ
Legend Biotech
AACR
Multiple Myeloma
Carvykti
Abecma
Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting
BioSpace
Wed, 04/19/23 - 11:21 am
Bridge Biotherapeutics
BBT-207
AACR
non-small cell lung cancer
AACR 2023 – Hippo makes a splash
EP Vantage
Wed, 04/19/23 - 10:07 am
Vivace Therapeutics
VT3989
AACR
Novartis
Sanofi
Ikena Oncology
AACR: Lilly challenges Amgen, Mirati with early KRAS data, heading for a field 'much less crowded than it seems'
Fierce Biotech
Tue, 04/18/23 - 10:18 pm
Eli Lilly
Amgen
Mirati Therapeutics
KRAS inhibitors
AACR
REGN5459 Delivers Dose-Dependent Responses in Relapsed/Refractory Myeloma
Onc Live
Tue, 04/18/23 - 09:49 am
Regeneron
AACR
REGN5459
relapsed or refractory multiple myeloma
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple combination
BioSpace
Mon, 04/17/23 - 11:21 am
Medivir
AACR
fostrox
cancer
AACR: Patient deaths taint Roche's industry-first early-stage liver cancer readout for Tecentriq and Avastin
Fierce Pharma
Sun, 04/16/23 - 11:26 pm
Roche
AACR
liver cancer
patient deaths
AACR: AstraZeneca offers first look at Imfinzi's resectable lung cancer showing, fueling a key debate
Fierce Pharma
Sun, 04/16/23 - 11:22 pm
AstraZeneca
AACR
Imfinzi
non-small cell lung cancer
AACR 2023 – Moderna's immunotherapeutic splash
EP Vantage
Wed, 03/22/23 - 10:03 am
AACR
Moderna Therapeutics
Allogene
AstraZeneca
Merck
Roche
Novartis
Eli Lilly
Innovent
Springworks
Biogene
Relay Therapeutics
Vivace Therapeutics
AACR: AbbVie's navitoclax goes after tough blood cancer, not yet reaching overall survival benchmark
Fierce Biotech
Tue, 04/12/22 - 08:31 pm
AACR
AbbVie
navitoclax
myelofibrosis
blood cancer
Novartis Highlights Early Data from Potential Lumakras Competitor at AACR
BioSpace
Tue, 04/12/22 - 10:49 am
Novartis
AACR
JDQ443
clinical trials
Amgen
Lumakras
AACR 2022 – A weekend of updates yields few winners
EP Vantage
Tue, 04/12/22 - 10:34 am
AACR
Bicycle Therapeutics
Rubius Therapeutics
C4 Therapeutics
Zentalis
Affimed
Seagen
Astellas
BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR
BioSpace
Mon, 04/11/22 - 10:56 am
BrickBio
antibody-drug conjugate
protein origami
AACR
Bicycle Therapeutics shares fall 23% after the company shares interim Phase 1 data
Marketwatch
Mon, 04/11/22 - 10:39 am
AACR
Bicycle Therapeutics
clinical trials
urothelial cancer
BT8009
AACR 2022 – Affimed shows that 2021 was no fluke
EP Vantage
Mon, 04/11/22 - 10:26 am
AACR
Affimed
AFM13
natural killer cells
AACR22: As post-Covid development takes shape, BioNTech reports first human data for CAR-T/cancer vaccine combo
Endpoints
Sun, 04/10/22 - 07:49 pm
AACR
BioNTech
clinical trials
CAR-T
MRNA
testicular cancer
ovarian cancer
AACR: 2 years in, Amgen fortifies Lumakras lung cancer data fortress for upcoming Mirati, Novartis KRAS battle
Fierce Pharma
Sun, 04/10/22 - 07:46 pm
AACR
Amgen
Lumakras
Mirati Therapeutics
AACR Preview: AstraZeneca to Showcase "Oncology Revolution"
BioSpace
Mon, 03/28/22 - 07:48 pm
AstraZeneca
oncology
AACR
At a Recent Cancer Research Conference, Instil Bio Stole the Show
Motley Fool
Thu, 04/29/21 - 10:30 am
Instil Bio
cancer
AACR
melanoma
Pages
1
2
3
next ›
last »